The proarrhythmic risk of cell therapy for cardiovascular diseases

References

• Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet367(9524), 1747–1757 (2006).
   PubMed Web of Science ®Google Scholar
• Velagaleti RS, Pencina MJ, Murabito JM et al. Long-term trends in the incidence of heart failure after myocardial infarction. Circulation118(20), 2057–2062 (2008).
   PubMed Web of Science ®Google Scholar
• Passier R, Van Laake LW, Mummery CL. Stem-cell-based therapy and lessons from the heart. Nature453(7193), 322–329 (2008).
   PubMed Web of Science ®Google Scholar
• Smart N, Riley PR. The stem cell movement. Circ. Res.102(10), 1155–1168 (2008).
   PubMed Web of Science ®Google Scholar
• Smith RR, Barile L, Messina E, Marban E. Stem cells in the heart: what’s the buzz all about? – Part 1: preclinical considerations. Heart Rhythm5(5), 749–757 (2008).
   PubMed Web of Science ®Google Scholar
• Zhu WZ, Hauch KD, Xu C, Laflamme MA. Human embryonic stem cells and cardiac repair. Transplant. Rev. (Orlando)23(1), 53–68 (2009).
   PubMedGoogle Scholar
• Orlic D, Kajstura J, Chimenti S et al. Bone marrow cells regenerate infarcted myocardium. Nature410(6829), 701–705 (2001).
   PubMed Web of Science ®Google Scholar
• Tse HF, Siu CW, Zhu SG et al. Paracrine effects of direct intramyocardial implantation of bone marrow derived cells to enhance neovascularization in chronic ischaemic myocardium. Eur. J. Heart Fail.9(8), 747–753 (2007).
   PubMed Web of Science ®Google Scholar
• Dai W, Hale SL, Martin BJ et al. Allogeneic mesenchymal stem cell transplantation in postinfarcted rat myocardium: short- and long-term effects. Circulation112(2), 214–223 (2005).
   PubMed Web of Science ®Google Scholar
• Makkar RR, Price MJ, Lill M et al. Intramyocardial injection of allogenic bone marrow-derived mesenchymal stem cells without immunosuppression preserves cardiac function in a porcine model of myocardial infarction. J. Cardiovasc. Pharmacol. Ther.10(4), 225–233 (2005).
   PubMed Web of Science ®Google Scholar
• Leobon B, Garcin I, Menasche P, Vilquin JT, Audinat E, Charpak S. Myoblasts transplanted into rat infarcted myocardium are functionally isolated from their host. Proc. Natl Acad. Sci. USA100(13), 7808–7811 (2003).
   PubMed Web of Science ®Google Scholar
• Taylor DA, Atkins BZ, Hungspreugs P et al. Regenerating functional myocardium: improved performance after skeletal myoblast transplantation. Nat. Med.4(8), 929–933 (1998).
   PubMed Web of Science ®Google Scholar
• Johnston PV, Sasano T, Mills K et al. Engraftment, differentiation, and functional benefits of autologous cardiosphere-derived cells in porcine ischemic cardiomyopathy. Circulation120(12), 1075–1083 (2009).
   PubMed Web of Science ®Google Scholar
• Linke A, Muller P, Nurzynska D et al. Stem cells in the dog heart are self-renewing, clonogenic, and multipotent and regenerate infarcted myocardium, improving cardiac function. Proc. Natl Acad. Sci. USA102(25), 8966–8971 (2005).
   PubMed Web of Science ®Google Scholar
• Van Laake LW, Passier R, Monshouwer-Kloots J et al. Human embryonic stem cell-derived cardiomyocytes survive and mature in the mouse heart and transiently improve function after myocardial infarction. Stem Cell Res.1(1), 9–24 (2007).
   PubMed Web of Science ®Google Scholar
• Liao SY, Liu Y, Siu CW et al. Proarrhythmic risk of embryonic stem cell-derived cardiomyocyte transplantation in infarcted myocardium. Heart Rhythm7(12), 1852–1859 (2010).
   PubMed Web of Science ®Google Scholar
• Tse HF, Kwong YL, Chan JK, Lo G, Ho CL, Lau CP. Angiogenesis in ischaemic myocardium by intramyocardial autologous bone marrow mononuclear cell implantation. Lancet361(9351), 47–49 (2003).
   PubMed Web of Science ®Google Scholar
• Meyer GP, Wollert KC, Lotz J et al. Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months’ follow-up data from the randomized, controlled BOOST (Bone Marrow Transfer to Enhance ST-Elevation Infarct Regeneration) trial. Circulation113(10), 1287–1294 (2006).
   PubMed Web of Science ®Google Scholar
• Dib N, Dinsmore J, Lababidi Z et al. One-year follow-up of feasibility and safety of the first U.S. randomized, controlled study using 3-dimensional guided catheter-based delivery of autologous skeletal myoblasts for ischemic cardiomyopathy (CAuSMIC study). JACC Cardiovasc. Interv.2(1), 9–16 (2009).
   PubMed Web of Science ®Google Scholar
• Hare JM, Traverse JH, Henry TD et al. A randomized, double-blind, placebo-controlled, dose–escalation study of intravenous adult human mesenchymal stem cells (Prochymal) after acute myocardial infarction. J. Am. Coll. Cardiol.54(24), 2277–2286 (2009).
   PubMed Web of Science ®Google Scholar
• Henning RJ. Stem cells in cardiac repair. Future Cardiol.7(1), 99–117 (2011).
   PubMedGoogle Scholar
• Menasche P. Stem cell therapy for heart failure: are arrhythmias a real safety concern? Circulation119(20), 2735–2740 (2009).
   PubMed Web of Science ®Google Scholar
• Chen HS, Kim C, Mercola M. Electrophysiological challenges of cell-based myocardial repair. Circulation120(24), 2496–2508 (2009).
   PubMed Web of Science ®Google Scholar
• Menasche P, Hagege AA, Vilquin JT et al. Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction. J. Am. Coll. Cardiol.41(7), 1078–1083 (2003).
   PubMed Web of Science ®Google Scholar
• Pagani FD, Dersimonian H, Zawadzka A et al. Autologous skeletal myoblasts transplanted to ischemia-damaged myocardium in humans. Histological analysis of cell survival and differentiation. J. Am. Coll. Cardiol.41(5), 879–888 (2003).
   PubMed Web of Science ®Google Scholar
• Mummery C, Ward-Van Oostwaard D, Doevendans P et al. Differentiation of human embryonic stem cells to cardiomyocytes: role of coculture with visceral endoderm-like cells. Circulation107(21), 2733–2740 (2003).
   PubMed Web of Science ®Google Scholar
• Davis DR, Ruckdeschel Smith R, Marban E. Human cardiospheres are a source of stem cells with cardiomyogenic potential. Stem Cells28(5), 903–904 (2010).
   PubMed Web of Science ®Google Scholar
• Zhang J, Wilson GF, Soerens AG et al. Functional cardiomyocytes derived from human induced pluripotent stem cells. Circ. Res.104(4), e30–e41 (2009).
   PubMed Web of Science ®Google Scholar
• Zhang YM, Hartzell C, Narlow M, Dudley SC Jr. Stem cell-derived cardiomyocytes demonstrate arrhythmic potential. Circulation106(10), 1294–1299 (2002).
   PubMed Web of Science ®Google Scholar
• Rubart M, Soonpaa MH, Nakajima H, Field LJ. Spontaneous and evoked intracellular calcium transients in donor-derived myocytes following intracardiac myoblast transplantation. J. Clin. Invest.114(6), 775–783 (2004).
   PubMed Web of Science ®Google Scholar
• Peters NS, Coromilas J, Severs NJ, Wit AL. Disturbed connexin43 gap junction distribution correlates with the location of reentrant circuits in the epicardial border zone of healing canine infarcts that cause ventricular tachycardia. Circulation95(4), 988–996 (1997).
   PubMed Web of Science ®Google Scholar
• Cao JM, Fishbein MC, Han JB et al. Relationship between regional cardiac hyperinnervation and ventricular arrhythmia. Circulation101(16), 1960–1969 (2000).
   PubMed Web of Science ®Google Scholar
• Chen PS, Chen LS, Cao JM, Sharifi B, Karagueuzian HS, Fishbein MC. Sympathetic nerve sprouting, electrical remodeling and the mechanisms of sudden cardiac death. Cardiovasc. Res.50(2), 409–416 (2001).
   PubMed Web of Science ®Google Scholar
• Pak HN, Qayyum M, Kim DT et al. Mesenchymal stem cell injection induces cardiac nerve sprouting and increased tenascin expression in a Swine model of myocardial infarction. J. Cardiovasc. Electrophysiol.14(8), 841–848 (2003).
   PubMed Web of Science ®Google Scholar
• Siu CW, Liao SY, Liu Y, Lian Q, Tse HF. Stem cells for myocardial repair. Thromb. Haemost.104(1), 6–12 (2010).
   PubMed Web of Science ®Google Scholar
• Takehara N, Matsubara H. Cardiac regeneration therapy: connections to cardiac physiology. Am. J. Physiol. Heart Circ. Physiol. doi:10.1152/ajpheart.00768.2011 (2011) (Epub ahead of print).
   PubMed Web of Science ®Google Scholar
• Gavira JJ, Nasarre E, Abizanda G et al. Repeated implantation of skeletal myoblast in a swine model of chronic myocardial infarction. Eur. Heart J.31(8), 1013–1021 (2010).
   PubMed Web of Science ®Google Scholar
• Gepstein L, Ding C, Rehemedula D et al.In vivo assessment of the electrophysiological integration and arrhythmogenic risk of myocardial cell transplantation strategies. Stem Cells28(12), 2151–2161 (2010).
   PubMed Web of Science ®Google Scholar
• Sherman W, He KL, Yi GH et al. Myoblast transfer in ischemic heart failure: effects on rhythm stability. Cell Transplant.18(3), 333–341 (2009).
   PubMed Web of Science ®Google Scholar
• Fernandes S, Amirault JC, Lande G et al. Autologous myoblast transplantation after myocardial infarction increases the inducibility of ventricular arrhythmias. Cardiovasc. Res.69(2), 348–358 (2006).
   PubMed Web of Science ®Google Scholar
• Herreros J, Prosper F, Perez A et al. Autologous intramyocardial injection of cultured skeletal muscle-derived stem cells in patients with non-acute myocardial infarction. Eur. Heart J.24(22), 2012–2020 (2003).
   PubMed Web of Science ®Google Scholar
• Ince H, Petzsch M, Rehders TC, Kische S, Chatterjee T, Nienaber CA. [Percutaneous transplantation of autologous myoblasts in ischemic cardiomyopathy]. Herz30(3), 223–231 (2005).
   PubMed Web of Science ®Google Scholar
• Smits PC, Van Geuns RJ, Poldermans D et al. Catheter-based intramyocardial injection of autologous skeletal myoblasts as a primary treatment of ischemic heart failure: clinical experience with six-month follow-up. J. Am. Coll. Cardiol.42(12), 2063–2069 (2003).
   PubMed Web of Science ®Google Scholar
• Duckers HJ, Houtgraaf J, Hehrlein C et al. Final results of a Phase IIa, randomised, open-label trial to evaluate the percutaneous intramyocardial transplantation of autologous skeletal myoblasts in congestive heart failure patients: the SEISMIC trial. EuroIntervention6(7), 805–812 (2011).
   PubMed Web of Science ®Google Scholar
• Menasche P, Alfieri O, Janssens S et al. The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) trial: first randomized placebo-controlled study of myoblast transplantation. Circulation117(9), 1189–1200 (2008).
   PubMed Web of Science ®Google Scholar
• Coppen SR, Fukushima S, Shintani Y et al. A factor underlying late-phase arrhythmogenicity after cell therapy to the heart: global downregulation of connexin43 in the host myocardium after skeletal myoblast transplantation. Circulation118(14 Suppl.), S138–S144 (2008).
   Google Scholar
• Roell W, Lewalter T, Sasse P et al. Engraftment of connexin 43-expressing cells prevents post-infarct arrhythmia. Nature450(7171), 819–824 (2007).
   PubMed Web of Science ®Google Scholar
• Joung B, Kim IK, Lee MH, Yoo KJ, Kim SS. Bone marrow mononuclear stem cells transplanted in rat infarct myocardium improved the electrical conduction without evidence of proarrhythmic effects. Yonsei Med. J.48(5), 754–764 (2007).
   PubMed Web of Science ®Google Scholar
• Goodchild T, Pang W, Tondato F et al. Safety of intramyocardial injection of autologous bone marrow cells to treat myocardial ischemia in pigs. Cardiovasc. Revasc. Med.7(3), 136–145 (2006).
   PubMedGoogle Scholar
• Assmus B, Honold J, Schachinger V et al. Transcoronary transplantation of progenitor cells after myocardial infarction. N. Engl. J. Med.355(12), 1222–1232 (2006).
   PubMed Web of Science ®Google Scholar
• Hendrikx M, Hensen K, Clijsters C et al. Recovery of regional but not global contractile function by the direct intramyocardial autologous bone marrow transplantation: results from a randomized controlled clinical trial. Circulation114(Suppl. 1), I101–I107 (2006).
   Google Scholar
• Huikuri HV, Kervinen K, Niemela M et al. Effects of intracoronary injection of mononuclear bone marrow cells on left ventricular function, arrhythmia risk profile, and restenosis after thrombolytic therapy of acute myocardial infarction. Eur. Heart J.29(22), 2723–2732 (2008).
   PubMed Web of Science ®Google Scholar
• Janssens S, Dubois C, Bogaert J et al. Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial. Lancet367(9505), 113–121 (2006).
   PubMed Web of Science ®Google Scholar
• Lunde K, Solheim S, Aakhus S et al. Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. N. Engl. J. Med.355(12), 1199–1209 (2006).
   PubMed Web of Science ®Google Scholar
• Meluzin J, Mayer J, Groch L et al. Autologous transplantation of mononuclear bone marrow cells in patients with acute myocardial infarction: the effect of the dose of transplanted cells on myocardial function. Am. Heart J.152(5), 975.e979–e915 (2006).
   PubMed Web of Science ®Google Scholar
• Ruan W, Pan CZ, Huang GQ, Li YL, Ge JB, Shu XH. Assessment of left ventricular segmental function after autologous bone marrow stem cells transplantation in patients with acute myocardial infarction by tissue tracking and strain imaging. Chin. Med. J. (Engl.)118(14), 1175–1181 (2005).
   PubMed Web of Science ®Google Scholar
• Schachinger V, Assmus B, Britten MB et al. Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction: final one-year results of the TOPCARE-AMI Trial. J. Am. Coll. Cardiol.44(8), 1690–1699 (2004).
   PubMed Web of Science ®Google Scholar
• Schachinger V, Erbs S, Elsasser A et al. Improved clinical outcome after intracoronary administration of bone-marrow-derived progenitor cells in acute myocardial infarction: final 1-year results of the REPAIR-AMI trial. Eur. Heart J.27(23), 2775–2783 (2006).
   PubMed Web of Science ®Google Scholar
• Villa A, Sanchez PL, Fernandez-Aviles F. Ventricular arrhythmias following intracoronary bone marrow stem cell transplantation. Europace9(12), 1222–1223 (2007).
   PubMed Web of Science ®Google Scholar
• Fernandez-Aviles F, San Roman JA, Garcia-Frade J et al. Experimental and clinical regenerative capability of human bone marrow cells after myocardial infarction. Circ. Res.95(7), 742–748 (2004).
   PubMed Web of Science ®Google Scholar
• Rastan AJ, Walther T, Kostelka M et al. Morphological, electrophysiological and coupling characteristics of bone marrow-derived mononuclear cells – an in vitro-model. Eur. J. Cardiothorac. Surg.27(1), 104–110 (2005).
   PubMed Web of Science ®Google Scholar
• Sheu JJ, Sun CK, Chang LT et al. Shock wave-pretreated bone marrow cells further improve left ventricular function after myocardial infarction in rabbits. Ann. Vasc. Surg.24(6), 809–821 (2010).
   PubMed Web of Science ®Google Scholar
• Yip HK, Chang LT, Wu CJ et al. Autologous bone marrow-derived mononuclear cell therapy prevents the damage of viable myocardium and improves rat heart function following acute anterior myocardial infarction. Circ. J.72(8), 1336–1345 (2008).
   PubMed Web of Science ®Google Scholar
• Prockop DJ. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science276(5309), 71–74 (1997).
   PubMed Web of Science ®Google Scholar
• Zuk PA, Zhu M, Ashjian P et al. Human adipose tissue is a source of multipotent stem cells. Mol. Biol. Cell13(12), 4279–4295 (2002).
   PubMed Web of Science ®Google Scholar
• Mareschi K, Biasin E, Piacibello W, Aglietta M, Madon E, Fagioli F. Isolation of human mesenchymal stem cells: bone marrow versus umbilical cord blood. Haematologica86(10), 1099–1100 (2001).
   PubMed Web of Science ®Google Scholar
• Lian Q, Zhang Y, Zhang J et al. Functional mesenchymal stem cells derived from human induced pluripotent stem cells attenuate limb ischemia in mice. Circulation121(9), 1113–1123 (2010).
   PubMed Web of Science ®Google Scholar
• Pijnappels DA, Schalij MJ, Ramkisoensing AA et al. Forced alignment of mesenchymal stem cells undergoing cardiomyogenic differentiation affects functional integration with cardiomyocyte cultures. Circ. Res.103(2), 167–176 (2008).
   PubMed Web of Science ®Google Scholar
• Rose RA, Jiang H, Wang X et al. Bone marrow-derived mesenchymal stromal cells express cardiac-specific markers, retain the stromal phenotype, and do not become functional cardiomyocytes in vitro. Stem Cells26(11), 2884–2892 (2008).
   PubMed Web of Science ®Google Scholar
• Quevedo HC, Hatzistergos KE, Oskouei BN et al. Allogeneic mesenchymal stem cells restore cardiac function in chronic ischemic cardiomyopathy via trilineage differentiating capacity. Proc. Natl Acad. Sci. USA106(33), 14022–14027 (2009).
   PubMed Web of Science ®Google Scholar
• Shake JG, Gruber PJ, Baumgartner WA et al. Mesenchymal stem cell implantation in a swine myocardial infarct model: engraftment and functional effects. Ann. Thorac. Surg.73(6), 1919–1925; discussion 1926 (2002).
   PubMed Web of Science ®Google Scholar
• Mills WR, Mal N, Kiedrowski MJ et al. Stem cell therapy enhances electrical viability in myocardial infarction. J. Mol. Cell. Cardiol.42(2), 304–314 (2007).
   PubMed Web of Science ®Google Scholar
• Wang D, Zhang F, Shen W et al. Mesenchymal stem cell injection ameliorates the inducibility of ventricular arrhythmias after myocardial infarction in rats. Int. J. Cardiol.152(3), 314–320 (2010).
   PubMed Web of Science ®Google Scholar
• Krause K, Schneider C, Lange C et al. Endocardial electrogram analysis after intramyocardial injection of mesenchymal stem cells in the chronic ischemic myocardium. Pacing Clin. Electrophysiol.32(10), 1319–1328 (2009).
   PubMed Web of Science ®Google Scholar
• Chen M, Fan ZC, Liu XJ et al. Effects of autologous stem cell transplantation on ventricular electrophysiology in doxorubicin-induced heart failure. Cell Biol. Int.30(7), 576–582 (2006).
   PubMed Web of Science ®Google Scholar
• Price MJ, Chou CC, Frantzen M et al. Intravenous mesenchymal stem cell therapy early after reperfused acute myocardial infarction improves left ventricular function and alters electrophysiologic properties. Int. J. Cardiol.111(2), 231–239 (2006).
   PubMed Web of Science ®Google Scholar
• Chen SL, Fang WW, Qian J et al. Improvement of cardiac function after transplantation of autologous bone marrow mesenchymal stem cells in patients with acute myocardial infarction. Chin. Med. J. (Engl.)117(10), 1443–1448 (2004).
   PubMed Web of Science ®Google Scholar
• Katritsis DG, Sotiropoulou PA, Karvouni E et al. Transcoronary transplantation of autologous mesenchymal stem cells and endothelial progenitors into infarcted human myocardium. Catheter Cardiovasc. Interv.65(3), 321–329 (2005).
   PubMed Web of Science ®Google Scholar
• Chen S, Liu Z, Tian N et al. Intracoronary transplantation of autologous bone marrow mesenchymal stem cells for ischemic cardiomyopathy due to isolated chronic occluded left anterior descending artery. J. Invasive Cardiol.18(11), 552–556 (2006).
   PubMedGoogle Scholar
• Katritsis DG, Sotiropoulou P, Giazitzoglou E, Karvouni E, Papamichail M. Electrophysiological effects of intracoronary transplantation of autologous mesenchymal and endothelial progenitor cells. Europace9(3), 167–171 (2007).
   PubMed Web of Science ®Google Scholar
• Yang Z, Zhang F, Ma W et al. A novel approach to transplanting bone marrow stem cells to repair human myocardial infarction: delivery via a noninfarct-relative artery. Cardiovasc. Ther.28(6), 380–385 (2010).
   PubMed Web of Science ®Google Scholar
• Trachtenberg B, Velazquez DL, Williams AR et al. Rationale and design of the Transendocardial Injection of Autologous Human Cells (bone marrow or mesenchymal) in Chronic Ischemic Left Ventricular Dysfunction and Heart Failure Secondary to Myocardial Infarction (TAC-HFT) trial: a randomized, double-blind, placebo-controlled study of safety and efficacy. Am. Heart J.161(3), 487–493 (2011).
   PubMed Web of Science ®Google Scholar
• Valiunas V, Doronin S, Valiuniene L et al. Human mesenchymal stem cells make cardiac connexins and form functional gap junctions. J. Physiol.555(Pt 3), 617–626 (2004).
   PubMed Web of Science ®Google Scholar
• Beeres SL, Atsma DE, Van Der Laarse A et al. Human adult bone marrow mesenchymal stem cells repair experimental conduction block in rat cardiomyocyte cultures. J. Am. Coll. Cardiol.46(10), 1943–1952 (2005).
   PubMed Web of Science ®Google Scholar
• Chang MG, Tung L, Sekar RB et al. Proarrhythmic potential of mesenchymal stem cell transplantation revealed in an in vitro coculture model. Circulation113(15), 1832–1841 (2006).
   PubMed Web of Science ®Google Scholar
• Heubach JF, Graf EM, Leutheuser J et al. Electrophysiological properties of human mesenchymal stem cells. J. Physiol.554(Pt 3), 659–672 (2004).
   PubMed Web of Science ®Google Scholar
• Woodbury D, Schwarz EJ, Prockop DJ, Black IB. Adult rat and human bone marrow stromal cells differentiate into neurons. J. Neurosci. Res.61(4), 364–370 (2000).
   PubMed Web of Science ®Google Scholar
• Santos PM, Winterowd JG, Allen GG, Bothwell MA, Rubel EW. Nerve growth factor: increased angiogenesis without improved nerve regeneration. Otolaryngol. Head Neck Surg.105(1), 12–25 (1991).
   PubMed Web of Science ®Google Scholar
• Kim SK, Pak HN, Park JH et al. Cardiac cell therapy with mesenchymal stem cell induces cardiac nerve sprouting, angiogenesis, and reduced connexin43-positive gap junctions, but concomitant electrical pacing increases connexin43-positive gap junctions in canine heart. Cardiol. Young20(3), 308–317 (2010).
   PubMed Web of Science ®Google Scholar
• Beltrami AP, Urbanek K, Kajstura J et al. Evidence that human cardiac myocytes divide after myocardial infarction. N. Engl. J. Med.344(23), 1750–1757 (2001).
   PubMed Web of Science ®Google Scholar
• Smart N, Bollini S, Dube KN et al.De novo cardiomyocytes from within the activated adult heart after injury. Nature474(7353), 640–644 (2011).
   PubMed Web of Science ®Google Scholar
• Beltrami AP, Barlucchi L, Torella D et al. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell114(6), 763–776 (2003).
   PubMed Web of Science ®Google Scholar
• Messina E, De Angelis L, Frati G et al. Isolation and expansion of adult cardiac stem cells from human and murine heart. Circ. Res.95(9), 911–921 (2004).
   PubMed Web of Science ®Google Scholar
• Davis DR, Kizana E, Terrovitis J et al. Isolation and expansion of functionally-competent cardiac progenitor cells directly from heart biopsies. J. Mol. Cell. Cardiol.49(2), 312–321 (2010).
   PubMed Web of Science ®Google Scholar
• Smith RR, Barile L, Cho HC et al. Regenerative potential of cardiosphere-derived cells expanded from percutaneous endomyocardial biopsy specimens. Circulation115(7), 896–908 (2007).
   PubMed Web of Science ®Google Scholar
• Zheng S, Zhou C, Weng Y et al. Improvements of cardiac electrophysiologic stability and ventricular fibrillation threshold in rats with myocardial infarction treated with cardiac stem cells. Crit. Care Med.39(5), 1082–1088 (2011).
   PubMed Web of Science ®Google Scholar
• Rota M, Padin-Iruegas ME, Misao Y et al. Local activation or implantation of cardiac progenitor cells rescues scarred infarcted myocardium improving cardiac function. Circ. Res.103(1), 107–116 (2008).
   PubMed Web of Science ®Google Scholar
• Kehat I, Kenyagin-Karsenti D, Snir M et al. Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. J. Clin. Invest.108(3), 407–414 (2001).
   PubMed Web of Science ®Google Scholar
• Xu C, Police S, Rao N, Carpenter MK. Characterization and enrichment of cardiomyocytes derived from human embryonic stem cells. Circ. Res.91(6), 501–508 (2002).
   PubMed Web of Science ®Google Scholar
• Himes N, Min JY, Lee R et al.In vivo MRI of embryonic stem cells in a mouse model of myocardial infarction. Magn. Reson. Med.52(5), 1214–1219 (2004).
   PubMed Web of Science ®Google Scholar
• Hodgson DM, Behfar A, Zingman LV et al. Stable benefit of embryonic stem cell therapy in myocardial infarction. Am. J. Physiol. Heart Circ. Physiol.287(2), H471–H479 (2004).
   PubMed Web of Science ®Google Scholar
• Kofidis T, De Bruin JL, Hoyt G et al. Myocardial restoration with embryonic stem cell bioartificial tissue transplantation. J. Heart Lung Transplant.24(6), 737–744 (2005).
   PubMed Web of Science ®Google Scholar
• Menard C, Hagege AA, Agbulut O et al. Transplantation of cardiac-committed mouse embryonic stem cells to infarcted sheep myocardium: a preclinical study. Lancet366(9490), 1005–1012 (2005).
   PubMed Web of Science ®Google Scholar
• Min JY, Yang Y, Converso KL et al. Transplantation of embryonic stem cells improves cardiac function in postinfarcted rats. J. Appl. Physiol.92(1), 288–296 (2002).
   PubMed Web of Science ®Google Scholar
• Laflamme MA, Chen KY, Naumova AV et al. Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nat. Biotechnol.25(9), 1015–1024 (2007).
   PubMed Web of Science ®Google Scholar
• Laflamme MA, Gold J, Xu C et al. Formation of human myocardium in the rat heart from human embryonic stem cells. Am. J. Pathol.167(3), 663–671 (2005).
   PubMed Web of Science ®Google Scholar
• Kehat I, Khimovich L, Caspi O et al. Electromechanical integration of cardiomyocytes derived from human embryonic stem cells. Nat. Biotechnol.22(10), 1282–1289 (2004).
   PubMed Web of Science ®Google Scholar
• Caspi O, Huber I, Kehat I et al. Transplantation of human embryonic stem cell-derived cardiomyocytes improves myocardial performance in infarcted rat hearts. J. Am. Coll. Cardiol.50(19), 1884–1893 (2007).
   PubMed Web of Science ®Google Scholar
• Nussbaum J, Minami E, Laflamme MA et al. Transplantation of undifferentiated murine embryonic stem cells in the heart: teratoma formation and immune response. FASEB J.21(7), 1345–1357 (2007).
   PubMed Web of Science ®Google Scholar
• He JQ, Ma Y, Lee Y, Thomson JA, Kamp TJ. Human embryonic stem cells develop into multiple types of cardiac myocytes: action potential characterization. Circ. Res.93(1), 32–39 (2003).
   PubMed Web of Science ®Google Scholar
• Xue T, Cho HC, Akar FG et al. Functional integration of electrically active cardiac derivatives from genetically engineered human embryonic stem cells with quiescent recipient ventricular cardiomyocytes: insights into the development of cell-based pacemakers. Circulation111(1), 11–20 (2005).
   PubMed Web of Science ®Google Scholar
• Kofidis T, De Bruin JL, Hoyt G et al. Injectable bioartificial myocardial tissue for large-scale intramural cell transfer and functional recovery of injured heart muscle. J. Thorac. Cardiovasc. Surg.128(4), 571–578 (2004).
   PubMed Web of Science ®Google Scholar
• Min JY, Yang Y, Sullivan MF et al. Long-term improvement of cardiac function in rats after infarction by transplantation of embryonic stem cells. J. Thorac. Cardiovasc. Surg.125(2), 361–369 (2003).
   PubMed Web of Science ®Google Scholar
• Dib N, Michler RE, Pagani FD et al. Safety and feasibility of autologous myoblast transplantation in patients with ischemic cardiomyopathy: four-year follow-up. Circulation112(12), 1748–1755 (2005).
   PubMed Web of Science ®Google Scholar